STIM

Healthcare Medical Devices

Neuronetics, Inc.

$2.20

+0.00 +0.23% today Live

Price History

Not enough data

Price chart data
Date	Price
Oct 6, 2026, live at 10:14 AM ET	2.20

Key Stats

Market Cap

168.01M

Avg Volume

2.08M

EPS

-$0.43

52W High

$3.44

52W Low

$0.80

Div. Yield

0.0%

Analyst Ratings

Buy

Str Buy

Buy

Hold

Sell

Str Sell

Valuation

Forward P/E

-6.49

P/B Ratio

9.42

P/S Ratio

1.08

EV/EBITDA

-12.39

EV/Revenue

1.54

Margins

Gross Margin 49.4%

Operating Margin (3.6%)

Net Margin (19.6%)

EBITDA Margin (12.4%)

Growth & Returns

Revenue Growth (YoY)

9.1%

Return on Equity

(116.1%)

Return on Assets

(10.5%)

Liquidity & Leverage

Current Ratio

1.88

Quick Ratio

1.25

Debt / Equity

4.00

Total Cash

19.20M

Total Debt

86.52M

About

Neuronetics, Inc. engages in providing in office treatments for patients with neurohealth disorders in the United States and internationally. The company provides NeuroStar Advanced Therapy System, a non-invasive and non-systemic office-based treatment to treat adult patients with major depressive disorder. Its NeuroStar Advanced Therapy System uses transcranial magnetic stimulation to create a pulsed, MRI-strength magnetic field that induces electrical currents designed to stimulate specific areas of the brain associated with mood. The company sells its products through its sales and customer support team to psychiatrists. Neuronetics, Inc. has a strategic collaboration with ANT Neuro to expand the capabilities of the NeuroStar advanced therapy system with advanced image-guided navigation technology. The company was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.

neurostar.com/neuronetics